Related references
Note: Only part of the references are listed.Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study
Hanzhi Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis
Parveen K. Garg et al.
ATHEROSCLEROSIS (2015)
The Association between Serum Uric Acid Levels and the Prevalence of Vulnerable Atherosclerotic Carotid Plaque: A Cross-sectional Study
Qing Li et al.
SCIENTIFIC REPORTS (2015)
Cognitive Tests to Detect Dementia A Systematic Review and Meta-analysis
Kelvin K. F. Tsoi et al.
JAMA INTERNAL MEDICINE (2015)
Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1
Tiziana Bacchetti et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study
Annette L. Fitzpatrick et al.
ATHEROSCLEROSIS (2014)
Test Accuracy of Cognitive Screening Tests for Diagnosis of Dementia and Multidomain Cognitive Impairment in Stroke
Rosalind Lees et al.
STROKE (2014)
Disposition and Metabolism of Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Humans
Mehul Dave et al.
DRUG METABOLISM AND DISPOSITION (2014)
Identifying cognitive impairment in heart failure: A review of screening measures
Karen K. Davis et al.
HEART & LUNG (2013)
The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
Alain Koyama et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Association between Non-High-Density-Lipoprotein-Cholesterol Levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis
Jianwei Wu et al.
PLOS ONE (2013)
Measures of Adiposity and Risk of Stroke in China: A Result from the Kailuan Study
Anxin Wang et al.
PLOS ONE (2013)
Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics
Yong Zhou et al.
PLOS ONE (2013)
Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease Results From the Framingham Heart Study
Thomas M. van Himbergen et al.
ARCHIVES OF NEUROLOGY (2012)
Prevalence of Ideal Cardiovascular Health and Its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City
Shouling Wu et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study
Julie E. Davidson et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease
Vincenza Frisardi et al.
AGEING RESEARCH REVIEWS (2010)
Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms
Vincenzo Solfrizzi et al.
AGEING RESEARCH REVIEWS (2010)
Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials
Philip B. Gorelick
INNATE INFLAMMATION AND STROKE (2010)
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
LANCET (2010)
Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study
Renate Schnabel et al.
ATHEROSCLEROSIS (2009)
Lipoprotein-Associated Phospholipase A2 and High-Sensitivity C-Reactive Protein Improve the Stratification of Ischemic Stroke Risk in the Atherosclerosis Risk in Communities (ARIC) Study
Vijay Nambi et al.
STROKE (2009)
Inflammation and rate of cognitive change in high-functioning older adults
Dawn E. Alley et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2008)
Inflammatory markers and cognitive function in middle-aged adults: The Whitehall II study
David Gimeno et al.
PSYCHONEUROENDOCRINOLOGY (2008)
Lipoprotein-associated phospholipase A(2): a new biomarker for cardiovascular risk assessment and potential therapeutic target
John F. Carlquist et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis - The Rotterdam study
I Kardys et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Lipoprotein-associated phospholipase A2 is associated with risk of dementia
M van Oijen et al.
ANNALS OF NEUROLOGY (2006)
Cardiovascular disease and Alzheimer's disease: common links
M. J. Stampfer
JOURNAL OF INTERNAL MEDICINE (2006)
Serum inflammatory proteins and cognitive decline in older persons
MG Dik et al.
NEUROLOGY (2005)
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke - The Rotterdam Study
HHS Oei et al.
CIRCULATION (2005)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
